BioCentury
ARTICLE | Distillery Therapeutics

Hematology

September 10, 2018 7:30 PM UTC

Cell culture and mouse studies suggest inhibiting STAB2 could help treat von Willebrand disease, which is caused by deficiencies in the Factor VIII carrier vWF. In a mouse model of von Willebrand dise...